Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy

Neuron

Volumn 82, Issue 2, 2014, Pages 295-307

  Cortes, Constanza J ^a   Ling, Shuo Chien ^b,j   Guo, Ling T ^c   Hung, Gene ^d   Tsunemi, Taiji ^a,k   Ly, Linda ^a   Tokunaga, Seiya ^b   Lopez, Edith ^a   Sopher, Bryce L ^e   Bennett, C Frank ^d   Shelton, G Diane ^c   Cleveland, Don W ^b,f   La Spada, Albert R ^a,b,f,g,h,i  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ISIS PHARMACEUTICALS   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ RADY CHILDREN'S HOSPITAL   (United States)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^k NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTINS; AGE FACTORS; ANIMALS; BODY WEIGHT; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MOVEMENT DISORDERS; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DISORDERS, ATROPHIC; PEPTIDES; PHENOTYPE; RECEPTORS, ANDROGEN;

EID: 84898685176     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.03.001     Document Type: Article

References (50)

1. Arnold E.S., Ling S.C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., Kordasiewicz H.B., McAlonis-Downes M., Platoshyn O., Parone P.A., et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA 2013, 110:E736-E745.
2. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004, 429:413-417.
3. Benatar M., Wuu J., Fernandez C., Weihl C.C., Katzen H., Steele J., Oskarsson B., Taylor J.P. Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology 2013, 80:1874-1880.
4. Boillée S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
5. Bosch-Marcé M., Wee C.D., Martinez T.L., Lipkes C.E., Choe D.W., Kong L., Van Meerbeke J.P., Musarò A., Sumner C.J. Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum. Mol. Genet. 2011, 20:1844-1853.
6. Brennan K.J., Hardeman E.C. Quantitative analysis of the human alpha-skeletal actin gene in transgenic mice. J.Biol. Chem. 1993, 268:719-725.
7. Bricceno K.V., Fischbeck K.H., Burnett B.G. Neurogenic and myogenic contributions to hereditary motor neuron disease. Neurodegener. Dis. 2012, 9:199-209.
8. Cifuentes-Diaz C., Frugier T., Tiziano F.D., Lacène E., Roblot N., Joshi V., Moreau M.H., Melki J. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J.Cell Biol. 2001, 152:1107-1114.
9. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillée S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302:113-117.
10. Custer S.K., Garden G.A., Gill N., Rueb U., Libby R.T., Schultz C., Guyenet S.J., Deller T., Westrum L.E., Sopher B.L., La Spada A.R. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat. Neurosci. 2006, 9:1302-1311.
11. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
12. Dobrowolny G., Giacinti C., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., Musarò A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J.Cell Biol. 2005, 168:193-199.
13. Dobrowolny G., Aucello M., Rizzuto E., Beccafico S., Mammucari C., Boncompagni S., Belia S., Wannenes F., Nicoletti C., Del Prete Z., et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008, 8:425-436.
14. Duan C., Ren H., Gao S. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen. Comp. Endocrinol. 2010, 167:344-351.
15. Dubowitz V., Shewry C.A. Muscle Biopsy: A Practical Approach 2007, 21-37. Saunders, Philadelphia, PA. Third Edition.
16. Funakoshi H., Belluardo N., Arenas E., Yamamoto Y., Casabona A., Persson H., Ibáñez C.F. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 1995, 268:1495-1499.
17. Garden G.A., La Spada A.R. Intercellular (mis)communication in neurodegenerative disease. Neuron 2012, 73:886-901.
18. Garden G.A., Libby R.T., Fu Y.H., Kinoshita Y., Huang J., Possin D.E., Smith A.C., Martinez R.A., Fine G.C., Grote S.K., et al. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous Purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J.Neurosci. 2002, 22:4897-4905.
19. Hua Y., Sahashi K., Rigo F., Hung G., Horev G., Bennett C.F., Krainer A.R. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011, 478:123-126.
20. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J.Cell Biol. 2009, 187:761-772.
21. Johansen J.A., Yu Z., Mo K., Monks D.A., Lieberman A.P., Breedlove S.M., Jordan C.L. Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy. Neurobiol. Dis. 2009, 34:113-120.
22. Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 2013, 16:571-579.
23. Katsuno M., Adachi H., Minamiyama M., Waza M., Doi H., Kondo N., Mizoguchi H., Nitta A., Yamada K., Banno H., et al. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J.Neurosci. 2010, 30:5702-5712.
24. Katsuno M., Tanaka F., Adachi H., Banno H., Suzuki K., Watanabe H., Sobue G. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog. Neurobiol. 2012, 99:246-256.
25. La Spada A.R. Getting a handle on Huntington's disease: silencing neurodegeneration. Nat. Med. 2009, 15:252-253.
26. La Spada A.R., Taylor J.P. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat. Rev. Genet. 2010, 11:247-258.
27. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
28. Lefebvre S., Bürglen L., Reboullet S., Clermont O., Burlet P., Viollet L., Benichou B., Cruaud C., Millasseau P., Zeviani M., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80:155-165.
29. Lieberman A., Yu Z., Murray S., Peralta R., Low A., Shuling G., Yu X.X., Cortes C.J., Bennett C.F., Monia B.P., La Spada A.R., Hung G. Peripheral androgen receptor gene suppression rescues disease inmouse models of spinal and bulbar muscular atrophy. Cell Rep 2014, 7. Published online April 16, 2014. 10.1016/j.celrep.2014.02.008.
30. Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J.Neurosci. 2002, 22:4825-4832.
31. Livak K.J., Flood S.J., Marmaro J., Giusti W., Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 1995, 4:357-362.
32. Martinez T.L., Kong L., Wang X., Osborne M.A., Crowder M.E., Van Meerbeke J.P., Xu X., Davis C., Wooley J., Goldhamer D.J., et al. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J.Neurosci. 2012, 32:8703-8715.
33. Miller T.M., Kim S.H., Yamanaka K., Hester M., Umapathi P., Arnson H., Rizo L., Mendell J.R., Gage F.H., Cleveland D.W., Kaspar B.K. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 2006, 103:19546-19551.
34. Miniou P., Tiziano D., Frugier T., Roblot N., Le Meur M., Melki J. Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Res. 1999, 27:e27.
35. Mochel F., Charles P., Seguin F., Barritault J., Coussieu C., Perin L., Le Bouc Y., Gervais C., Carcelain G., Vassault A., et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS ONE 2007, 2:e647.
36. Monks D.A., Johansen J.A., Mo K., Rao P., Eagleson B., Yu Z., Lieberman A.P., Breedlove S.M., Jordan C.L. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. USA 2007, 104:18259-18264.
37. Murray L.M., Comley L.H., Thomson D., Parkinson N., Talbot K., Gillingwater T.H. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 2008, 17:949-962.
38. Mutsaers C.A., Wishart T.M., Lamont D.J., Riessland M., Schreml J., Comley L.H., Murray L.M., Parson S.H., Lochmüller H., Wirth B., et al. Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum. Mol. Genet. 2011, 20:4334-4344.
39. Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J.P., Sumner C.J., Fischbeck K.H., Pennuto M. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 2009, 63:316-328.
40. Pramatarova A., Laganière J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J.Neurosci. 2001, 21:3369-3374.
41. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
42. Sopher B.L., La Spada A.R. Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis. Gene 2006, 371:136-143.
43. Sopher B.L., Thomas P.S., LaFevre-Bernt M.A., Holm I.E., Wilke S.A., Ware C.B., Jin L.W., Libby R.T., Ellerby L.M., La Spada A.R. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 2004, 41:687-699.
44. Sorarù G., D'Ascenzo C., Polo A., Palmieri A., Baggio L., Vergani L., Gellera C., Moretto G., Pegoraro E., Angelini C. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J.Neurol. Sci. 2008, 264:100-105.
45. Tabebordbar M., Wang E.T., Wagers A.J. Skeletal muscle degenerative diseases and strategies for therapeutic muscle repair. Annu. Rev. Pathol. 2013, 8:441-475.
46. Tammela T.L. Endocrine prevention and treatment of prostate cancer. Mol. Cell. Endocrinol. 2012, 360:59-67.
47. Towne C., Raoul C., Schneider B.L., Aebischer P. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol. Ther. 2008, 16:1018-1025.
48. Wakabayashi K., Takahashi H., Takeda S., Ohama E., Ikuta F. Lewy bodies in the enteric nervous system in Parkinson's disease. Arch. Histol. Cytol. 1989, 52(Suppl):191-194.
49. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.
50. Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D.M., Lieberman A.P. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J.Clin. Invest. 2006, 116:2663-2672.